Artificial intelligence in colonoscopy ‐ Now on the market. What's next?

Adoption of artificial intelligence (AI) in clinical medicine is revolutionizing daily practice. In the field of colonoscopy, major endoscopy manufacturers have already launched their own AI products on the market with regulatory approval in Europe and Asia. This commercialization is strongly suppor...

Full description

Saved in:
Bibliographic Details
Published in:Journal of gastroenterology and hepatology Vol. 36; no. 1; pp. 7 - 11
Main Authors: Mori, Yuichi, Neumann, Helmut, Misawa, Masashi, Kudo, Shin‐ei, Bretthauer, Michael
Format: Journal Article
Language:English
Published: Australia Wiley Subscription Services, Inc 01.01.2021
Subjects:
Adenoma
Artificial intelligence
Clinical trials
Colon
Colonoscopy
Colorectal cancer
Colorectal polyps
Computer‐aided diagnosis
Endoscopy
Regulatory approval
Colorectal polyps
Computer-aided diagnosis
Colorectal cancer
ISSN:0815-9319, 1440-1746, 1440-1746
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Adoption of artificial intelligence (AI) in clinical medicine is revolutionizing daily practice. In the field of colonoscopy, major endoscopy manufacturers have already launched their own AI products on the market with regulatory approval in Europe and Asia. This commercialization is strongly supported by positive evidence that has been recently established through rigorously designed prospective trials and randomized controlled trials. According to some of the trials, AI tools possibly increase the adenoma detection rate by roughly 50% and contribute to a 7–20% reduction of colonoscopy‐related costs. Given that reliable evidence is emerging, together with active commercialization, this seems to be a good time for us to review and discuss the current status of AI in colonoscopy from a clinical perspective. In this review, we introduce the advantages and possible drawbacks of AI tools and explore their future potential including the possibility of obtaining reimbursement.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0815-9319
1440-1746
1440-1746
DOI:10.1111/jgh.15339